STOCK TITAN

Curaleaf Holdings Announces Buyout of Minority Partner in Curaleaf International

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Curaleaf Holdings (OTCQX: CURLF) has acquired the remaining equity stake in Curaleaf International Holdings Limited from a strategic institutional investor, bringing its ownership to 100%. The transaction, completed on July 2, 2025, was executed through a pre-existing Put/Call Option agreement from 2021.

The strategic investor chose to receive payment entirely in Curaleaf Subordinate Voting Shares, demonstrating confidence in the company's future. The Toronto Stock Exchange conditionally approved the share issuance on June 25, 2025. This consolidation strengthens Curaleaf's control over European operations and enhances strategic alignment across international markets.

Curaleaf Holdings (OTCQX: CURLF) ha acquisito la quota azionaria rimanente in Curaleaf International Holdings Limited da un investitore istituzionale strategico, portando la sua partecipazione al 100%. L'operazione, completata il 2 luglio 2025, è stata effettuata tramite un accordo Put/Call Option preesistente risalente al 2021.

L'investitore strategico ha scelto di ricevere il pagamento interamente in azioni subordinate con diritto di voto di Curaleaf, dimostrando fiducia nel futuro dell'azienda. La Borsa di Toronto ha approvato condizionatamente l'emissione delle azioni il 25 giugno 2025. Questa consolidazione rafforza il controllo di Curaleaf sulle operazioni europee e migliora l'allineamento strategico nei mercati internazionali.

Curaleaf Holdings (OTCQX: CURLF) ha adquirido la participación accionaria restante en Curaleaf International Holdings Limited de un inversor institucional estratégico, aumentando su propiedad al 100%. La transacción, completada el 2 de julio de 2025, se realizó mediante un acuerdo Put/Call Option preexistente de 2021.

El inversor estratégico optó por recibir el pago íntegramente en acciones subordinadas con derecho a voto de Curaleaf, demostrando confianza en el futuro de la compañía. La Bolsa de Valores de Toronto aprobó condicionalmente la emisión de acciones el 25 de junio de 2025. Esta consolidación fortalece el control de Curaleaf sobre las operaciones europeas y mejora la alineación estratégica en los mercados internacionales.

Curaleaf Holdings (OTCQX: CURLF)는 전략적 기관 투자자로부터 Curaleaf International Holdings Limited의 남은 지분을 인수하여 소유 지분을 100%로 확대했습니다. 이 거래는 2025년 7월 2일에 완료되었으며, 2021년에 체결된 기존의 풋/콜 옵션 계약을 통해 실행되었습니다.

전략적 투자자는 회사의 미래에 대한 신뢰를 나타내며 대금을 전액 Curaleaf 보통주 하위 의결권 주식으로 받기로 선택했습니다. 토론토 증권거래소는 2025년 6월 25일에 주식 발행을 조건부 승인했습니다. 이번 통합은 Curaleaf가 유럽 사업에 대한 통제력을 강화하고 국제 시장 전반에 걸쳐 전략적 정렬을 향상시키는 데 기여합니다.

Curaleaf Holdings (OTCQX: CURLF) a acquis la totalité des parts restantes de Curaleaf International Holdings Limited auprès d'un investisseur institutionnel stratégique, portant sa participation à 100%. La transaction, finalisée le 2 juillet 2025, a été réalisée via un accord d'option Put/Call existant depuis 2021.

L'investisseur stratégique a choisi de recevoir le paiement intégralement en actions subordonnées avec droit de vote de Curaleaf, témoignant de sa confiance dans l'avenir de l'entreprise. La Bourse de Toronto a approuvé conditionnellement l'émission des actions le 25 juin 2025. Cette consolidation renforce le contrôle de Curaleaf sur ses opérations européennes et améliore l'alignement stratégique sur les marchés internationaux.

Curaleaf Holdings (OTCQX: CURLF) hat den verbleibenden Anteil an Curaleaf International Holdings Limited von einem strategischen institutionellen Investor erworben und hält nun 100% der Anteile. Die Transaktion, die am 2. Juli 2025 abgeschlossen wurde, erfolgte im Rahmen einer bereits 2021 bestehenden Put/Call-Optionsvereinbarung.

Der strategische Investor entschied sich, die Zahlung vollständig in Curaleaf nachrangigen stimmberechtigten Aktien zu erhalten, was Vertrauen in die Zukunft des Unternehmens zeigt. Die Toronto Stock Exchange genehmigte die Aktienausgabe am 25. Juni 2025 unter Vorbehalt. Diese Konsolidierung stärkt Curaleafs Kontrolle über die europäischen Geschäfte und verbessert die strategische Ausrichtung auf den internationalen Märkten.

Positive
  • Acquisition of remaining stake brings European operations under 100% control
  • Strategic investor's choice to receive payment in shares signals confidence in company
  • Enhanced decision-making capability and strategic autonomy in European operations
  • Strengthened alignment across international markets
Negative
  • Share issuance for acquisition payment will result in dilution for existing shareholders

STAMFORD, Conn., July 8, 2025 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA, OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today announced that it has acquired the equity stake in Curaleaf International Holdings Limited ("Curaleaf International") previously held by a single strategic institutional investor. The transaction brings the Company's stake in its European holding company to 100%.

The transaction represents the completion of a Put/Call Option that was agreed with the strategic investor at the time of its participation in Curaleaf's original investment into Europe in 2021. Following the pricing mechanism incorporated in the Put/Call Option, the investor elected to receive the purchase entirely in Curaleaf Subordinate Voting Shares. The acquisition strengthens the Company's control over its European operations, enabling enhanced strategic alignment across international markets. The request of the strategic investor to settle the transaction for Company shares underscores the investor's long-term support and confidence in the future of Curaleaf.

The issuance of the Subordinate Voting Shares in connection with the transaction was conditionally approved by the Toronto Stock Exchange on June 25, 2025, subject to fulfilling customary listing conditions. The transaction was completed on July 2, 2025.

Boris Jordan, Executive Chairman of Curaleaf Holdings, Inc., commented:

"This consolidation of ownership of our European holding company enables us to streamline decision-making, strengthen alignment across regions, and accelerate our strategic initiatives in Europe with greater autonomy. This development marks another important milestone in Curaleaf's continued commitment to international expansion and long-term value creation for shareholders. We thank our partners for their long-standing support and belief in Curaleaf's future."

About Curaleaf Holdings

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to enhance lives by cultivating, sharing and celebrating the power of the plant. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf, Select, Grassroots, Find, Anthem and The Hemp Company provide industry-leading service, product selection and accessibility across the medical and adult use markets. Curaleaf International is powered by a strong presence in all stages of the supply chain. Its unique distribution network throughout Europe, Canada and Australasia brings together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Toronto Stock Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

About Curaleaf International

Curaleaf International is shaping the future of cannabis through its commitment to research and product excellence. Powered by a strong presence at all stages of the supply chain, its unique distribution network throughout Europe, Canada and Australasia brings together pioneering research with cutting-edge cultivation, extraction, and production. Amidst a rapid growth trajectory, the emphasis on quality and expertise aims to ensure the delivery of safe and legal cannabis.

Curaleaf International's network includes a clinic, pharmacy, and laboratory in the UK; cultivation and EU-GMP processing facilities in Portugal; an EU-GMP processing, quality assurance and research site in Spain; Four20 Pharma wholesaler and distributor in Germany; a Polish wholesaler and clinic; and the EU-GMP producer Northern Green Canada.

Curaleaf International is part of Curaleaf Holdings, Inc., a leading international producer and distributor of consumer cannabis products.

Forward-Looking Statements

This media advisory contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward-looking statements and information concerning the expected benefits of the acquisition on the European business and operations of Curaleaf, and the listing of shares issuable in connection with the acquisition on the Toronto Stock Exchange. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the Company with respect to the matters described in this new release, including the Company's ability to successfully realize the expected benefits of the acquisition, and the Company's ability to fulfill the listing conditions imposed by the Toronto Stock Exchange. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements, including the failure to realize the expected benefits of the acquisition. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors" the Company's Annual Information Form dated March 3, 2025 for the fiscal year ended December 31, 2024, and as described from time to time in documents filed by the Company with Canadian securities regulatory authorities. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Toronto Stock Exchange has not reviewed, approved or disapproved of the content of this news release.

Investor Contact:
Curaleaf Holdings, Inc.
Camilo Lyon, Chief Investment Officer
IR@curaleaf.com

Media Contact:
Curaleaf Holdings, Inc.
Jordon Rahmil, VP Public Relations
media@curaleaf.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/curaleaf-holdings-announces-buyout-of-minority-partner-in-curaleaf-international-302499684.html

SOURCE Curaleaf Holdings, Inc.

FAQ

What stake did Curaleaf (CURLF) acquire in Curaleaf International?

Curaleaf acquired the remaining minority stake in Curaleaf International from a strategic institutional investor, bringing its ownership to 100%.

How will Curaleaf pay for the Curaleaf International stake acquisition?

The strategic investor elected to receive payment entirely in Curaleaf Subordinate Voting Shares.

When was the Curaleaf International acquisition completed?

The transaction was completed on July 2, 2025, with Toronto Stock Exchange conditional approval received on June 25, 2025.

What are the benefits of Curaleaf's full ownership of Curaleaf International?

Full ownership enables streamlined decision-making, stronger alignment across regions, and greater autonomy in executing European strategic initiatives.

When was the original Put/Call Option agreement established?

The Put/Call Option agreement was established in 2021 when the strategic investor first participated in Curaleaf's European investment.
Curaleaf Hldgs

OTC:CURLF

CURLF Rankings

CURLF Latest News

CURLF Stock Data

766.85M
600.66M
29.37%
1.65%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
New York